Advertisement
Taking Action

Policy

  • A Look at Disparities Across Cancer Care

    A new AACR report tracks progress in addressing cancer health disparities and identifies work that still needs to be done.

    by Eric Fitzsimmons

  • Policy Matters

    Patient Advocacy Is Driving Change

    Patient advocates strengthen every aspect of research, from funding innovative science and informing research design, to leading efforts on Capitol Hill to build support for research.

    by Carrie Treadwell, MBA

  • Understanding Stress and Cancer

    A symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.

    by Eric Fitzsimmons

  • The Impact of the RACE for Children Act

    Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.

    by Marci A. Landsmann

  • Medicaid: A Partial Safety Net

    Expansions in coverage and eligibility through the Affordable Care Act have made Medicaid a lifeline for many people with cancer, but benefits vary from state to state.

    by Sharon Tregaskis

  • Forward Look

    Adequate Representation

    Medical oncologist Lola Fashoyin-Aje describes the Food and Drug Administration’s efforts to make clinical trials more inclusive.

    by Erin O'Donnell

  • February 4: The Week in Cancer News

    CAR T-cell therapy effects continue 10 years after treatment and first T-cell receptor therapeutic approved for uveal melanoma.

    by Eric Fitzsimmons

  • Policy Matters

    Cancer Research: The Key to Tomorrow’s Cures

    The AACR is engaging with Congress and the Biden administration on the importance of funding for cancer research.

    by David A. Tuveson, MD, PhD

  • Facts and Stats

    Fifty Years of Growing Survivorship

    More people in the U.S. are alive after being diagnosed with cancer than ever before.

    by Eric Fitzsimmons

  • December 3: The Week in Cancer News

    Some cancer centers scrutinized for lack of pricing transparency, and an imaging drug helps surgeons better identify ovarian cancer with fluorescent lighting.

    by Marci A. Landsmann